Valuation (59%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | 37.16 | N/A |
| PEG Ratio (TTM) | 67.26 | N/A |
| P/S Ratio (TTM) | 12.12 | N/A |
| P/B Ratio (TTM) | 1.33 | N/A |
| P/FCF Ratio (TTM) | 16.75 | N/A |
| Price to 5YR AVG Earnings Ratio | 37.84 | N/A |
| Price to 5YR AVG FCF Ratio | 28.66 | N/A |
Profitability (40%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | 2.32% | N/A |
| ROE (TTM) | 3.65% | N/A |
| Net Profit Margin (TTM) | 31.62% | N/A |
| ROIC 5YR AVG | 3.49% | N/A |
Growth (70%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | 1.89% | -0.07% | -1.01% |
| Revenue | 3.07% | 35.12% | 29.76% |
| Net Income | 2.84% | 28.53% | 24.35% |
| Cash Flow | 8.93% | 40.34% | 35.23% |
Health (39%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | 0.74 | N/A |
| Quick Ratio (TTM) | 0.74 | N/A |
| D/E Ratio (TTM) | 0.51 | N/A |
| Interest Coverage (TTM) | 2.91 | N/A |
| Piotroski F-Score | 6 | N/A |
| Altman Z-Score | 1.62 | N/A |
| LTL to 5YR AVG FCF | 9.56 | N/A |
| Shares Outstanding Growth 5YR AVG | 24.38% | N/A |